{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-22-000037","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2022-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.605177+00:00","generated_at":"2026-06-21T08:35:27.370821+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Charles River Labs appoints Dr. Craig B. Thompson to Board","bullets":["Board expanded from 10 to 11; Dr. Thompson appointed effective Dec. 5, 2022.","Appointed to Science & Technology Committee and Strategic Planning & Capital Allocation Committee.","Initial pro-rata equity award valued at $255,500 (50% RSUs, 50% stock options).","Thompson is former CEO of Memorial Sloan Kettering (2010-2022) and current Regeneron board member."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-22-000037","json":"https://secwatch.observer/filing/0001100682-22-000037.json","markdown":"https://secwatch.observer/filing/0001100682-22-000037.md","text":"https://secwatch.observer/filing/0001100682-22-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000037/0001100682-22-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000037/crl-20221205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T08:35:27.370821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38b9605021","claim":"Craig B. Thompson was appointed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..","evidence_excerpt":"Following the size increase of the Board, the Board filled the vacancy and appointed Dr. Craig B. Thompson to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000037/0001100682-22-000037-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}